ArticleClinical and experimental immunology2022
Exosomal PD-L1 predicts response with immunotherapy in NSCLC patients.
Yuting Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this paperpooled ittrialcites it